This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Ball Corp, Crown Holdings and Silgan Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ball Corp, Crown Holdings and Silgan Holdings
Metal Can Makers Investing in Capacity to Meet Strong Demand
by Madhurima Das
Banking on the growing preference for metal cans worldwide thanks to its recyclability, companies like BLL, CCK and SLGN are investing in growing capacity.
Crown Holdings (CCK) & Velox Tie Up to Offer Digital Solution
by Zacks Equity Research
The latest technology helps Crown Holdings (CCK) advance digital printing for beverage cans with greater speed, high quality, top-notch design and features.
Silgan (SLGN) Invests $274 Million in Easytech & Unicep Buyouts
by Zacks Equity Research
Silgan's (SLGN) latest acquisitions are anticipated to provide a slight boost to the current-year earnings.
Silgan (SLGN) Acquires Easytech, Expands Metal Ends Capacity
by Zacks Equity Research
Silgan's (SLGN) latest buyout will enable it to efficiently utilize its existing capacity for metal ends, reduce capital investment and accelerate the company's cost-reduction program.
Silgan (SLGN) Buys Unicep Packaging, Expands Capabilities
by Zacks Equity Research
Silgan (SLGN) acquires Unicep Packaging which makes precision dosing dispensing packaging solutions for use in diagnostics, health and personal care.
Silgan (SLGN) Acquires Gateway Plastics for $485 Million
by Zacks Equity Research
Silgan's (SLGN) latest buyout is likely to be slightly accretive to its bottom-line performance in the current year.
Silgan (SLGN) Rides on Demand in Certain Markets Amid Cost Woes
by Zacks Equity Research
Ongoing solid demand in certain markets and continued manufacturing efficiencies will help Silgan (SLGN) counter the impact of higher input costs.
Why Hold Strategy is Apt for Silgan (SLGN) Stock Right Now
by Zacks Equity Research
Silgan (SLGN) is worth retaining in the portfolio with forecast-topping Q2 results, solid demand, acquisitions and focus on cost-reduction actions.
Silgan (SLGN) Up 5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Silgan (SLGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Silgan (SLGN) Earnings and Sales Beat Estimates in Q2
by Zacks Equity Research
Silgan's (SLGN) Q2 results gain from solid demand recovery in the beverage, beauty and fragrance markets.
Silgan Holdings (SLGN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Silgan (SLGN) delivered earnings and revenue surprises of 2.41% and 3.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Silgan Holdings (SLGN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Silgan (SLGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Metal Can Industry to Gain on Strong Demand: 3 Stocks to Watch
by Madhurima Das
With the increasing customer preference for metal cans thanks to their recyclability, companies like BLL, CCK and SLGN are poised well to gain from this trend.
Here's Why You Should Hold Silgan (SLGN) in Your Portfolio
by Zacks Equity Research
Forecast-topping first-quarter 2021 results, strong demand, strategic acquisitions and cost-reduction actions are bolstering Silgan's (SLGN) performance.
Why Is Silgan (SLGN) Down 0.3% Since Last Earnings Report?
by Zacks Equity Research
Silgan (SLGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Silgan (SLGN) Rides on Solid Demand & Buyouts Amid Cost Woes
by Zacks Equity Research
Silgan (SLGN) is benefiting from higher demand for food, beverage and consumer health and personal care products amid the coronavirus pandemic.
Silgan (SLGN) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Silgan (SLGN) delivers better-than-expected Q1 results on solid demand for personal care, hygiene and health care products.
Silgan Holdings (SLGN) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Silgan (SLGN) delivered earnings and revenue surprises of 5.63% and 1.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Silgan Holdings (SLGN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Silgan (SLGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SLGN (SLGN) Bets on Pandemic Driven Demand Amid High Debt
by Zacks Equity Research
Silgan Holdings (SLGN) is gaining on higher demand for food, beverage and consumer health and personal care products amid the coronavirus pandemic. Acquisitions will also drive growth.
Why Hold Strategy is Apt for Silgan (SLGN) Stock For Now
by Zacks Equity Research
Silgan (SLGN) is worth retaining in the portfolio at the moment, backed by encouraging Q4 results, robust demand for vital products and positive earnings growth estimates.
Silgan (SLGN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Silgan (SLGN) delivers better-than-expected fourth-quarter results and record 2020 results on solid demand for food, health and hygiene products. The trend is expected to aid 2021 results as well.
Silgan Holdings (SLGN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Silgan (SLGN) delivered earnings and revenue surprises of 13.21% and 3.75%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Avery Dennison (AVY) Rides on Strong Demand & Cost Savings
by Zacks Equity Research
Solid demand for its products amid the pandemic, strong liquidity position, expected savings from restructuring and acquisitions remain key catalysts for Avery Dennison (AVY).